• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-155 通过靶向 TAK1 结合蛋白 2 调节间充质干细胞的免疫调节特性。

miR-155 regulates immune modulatory properties of mesenchymal stem cells by targeting TAK1-binding protein 2.

机构信息

Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences/Shanghai Jiao Tong University School of Medicine, 225 South Chongqing Road, Shanghai 200025, China.

出版信息

J Biol Chem. 2013 Apr 19;288(16):11074-9. doi: 10.1074/jbc.M112.414862. Epub 2013 Feb 28.

DOI:10.1074/jbc.M112.414862
PMID:23449975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3630877/
Abstract

MSCs possess potent immunosuppressive capacity. We have reported that mouse MSCs inhibit T cell proliferation and function via nitric oxide. This immune regulatory capacity of MSCs is induced by the inflammatory cytokines IFNγ together with either TNFα or IL-1β. This effect of inflammatory cytokines on MSCs is extraordinary; logarithmic increases in the expression of iNOS and chemokines are often observed. To investigate the molecular mechanisms underlying this robust effect of cytokines, we examined the expression of microRNAs in MSCs before and after cytokine treatment. We found that miR-155 is most significantly up-regulated. Furthermore, our results showed that miR-155 inhibits the immunosuppressive capacity of MSCs by reducing iNOS expression. We further demonstrated that miR-155 targets TAK1-binding protein 2 (TAB2) to regulate iNOS expression. Additionally, knockdown of TAB2 reduced iNOS expression. In summary, our study demonstrated that miR-155 inhibits the immunosuppressive capacity of MSCs by reducing iNOS expression by targeting TAB2. Our data revealed a novel role of miR-155 in regulating the immune modulatory activities of MSCs.

摘要

间充质干细胞(MSCs)具有强大的免疫抑制能力。我们曾报道过,鼠源 MSCs 通过一氧化氮(NO)抑制 T 细胞的增殖和功能。MSCs 的这种免疫调节能力是由炎症细胞因子 IFNγ 与 TNFα 或 IL-1β 共同诱导产生的。炎症细胞因子对 MSCs 的这种作用非常显著,通常会观察到 iNOS 和趋化因子的表达呈对数增加。为了研究细胞因子这种强大作用的分子机制,我们在细胞因子处理前后检测了 MSCs 中的 microRNA 表达。结果发现 miR-155 的表达上调最为显著。此外,我们的结果表明,miR-155 通过降低 iNOS 的表达来抑制 MSCs 的免疫抑制能力。我们进一步证明,miR-155 通过靶向 TAK1 结合蛋白 2(TAB2)来调节 iNOS 的表达。此外,TAB2 的敲低也降低了 iNOS 的表达。综上所述,我们的研究表明,miR-155 通过靶向 TAB2 降低 iNOS 的表达,从而抑制 MSCs 的免疫抑制能力。我们的数据揭示了 miR-155 在调节 MSCs 免疫调节活性方面的新作用。

相似文献

1
miR-155 regulates immune modulatory properties of mesenchymal stem cells by targeting TAK1-binding protein 2.miR-155 通过靶向 TAK1 结合蛋白 2 调节间充质干细胞的免疫调节特性。
J Biol Chem. 2013 Apr 19;288(16):11074-9. doi: 10.1074/jbc.M112.414862. Epub 2013 Feb 28.
2
IFNγ and TNFα synergistically induce apoptosis of mesenchymal stem/stromal cells via the induction of nitric oxide.IFNγ 和 TNFα 通过诱导一氧化氮协同诱导间充质干细胞/基质细胞凋亡。
Stem Cell Res Ther. 2019 Jan 11;10(1):18. doi: 10.1186/s13287-018-1102-z.
3
Preconditioning of bone marrow-derived mesenchymal stem cells highly strengthens their potential to promote IL-6-dependent M2b polarization.骨髓间充质干细胞的预处理极大地增强了其促进 IL-6 依赖性 M2b 极化的潜力。
Stem Cell Res Ther. 2018 Oct 25;9(1):286. doi: 10.1186/s13287-018-1039-2.
4
Immunosuppressive effect of bone marrow-derived mesenchymal stem cells in inflammatory microenvironment favours the growth of B16 melanoma cells.骨髓间充质干细胞在炎症微环境中的免疫抑制作用有利于 B16 黑色素瘤细胞的生长。
J Cell Mol Med. 2011 Nov;15(11):2343-52. doi: 10.1111/j.1582-4934.2010.01215.x.
5
MiR-30a attenuates immunosuppressive functions of IL-1β-elicited mesenchymal stem cells via targeting TAB3.微小RNA-30a通过靶向TAB3减弱白细胞介素-1β诱导的间充质干细胞的免疫抑制功能。
FEBS Lett. 2015 Dec 21;589(24 Pt B):3899-907. doi: 10.1016/j.febslet.2015.11.001. Epub 2015 Nov 7.
6
Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide.间充质干细胞介导的免疫抑制通过趋化因子和一氧化氮的协同作用而发生。
Cell Stem Cell. 2008 Feb 7;2(2):141-50. doi: 10.1016/j.stem.2007.11.014.
7
Interleukin-17 enhances immunosuppression by mesenchymal stem cells.白细胞介素-17增强间充质干细胞的免疫抑制作用。
Cell Death Differ. 2014 Nov;21(11):1758-68. doi: 10.1038/cdd.2014.85. Epub 2014 Jul 18.
8
C/EBPbeta mediates synergistic upregulation of gene expression by interferon-gamma and tumor necrosis factor-alpha in bone marrow-derived mesenchymal stem cells.C/EBPβ介导骨髓间充质干细胞中干扰素-γ和肿瘤坏死因子-α对基因表达的协同上调作用。
Stem Cells. 2009 Apr;27(4):942-8. doi: 10.1002/stem.22.
9
IFN-γ and TNF-α synergistically induce microRNA-155 which regulates TAB2/IP-10 expression in human mesangial cells.干扰素-γ和肿瘤坏死因子-α协同诱导微小RNA-155,其可调节人系膜细胞中TAB2/IP-10的表达。
Am J Nephrol. 2010;32(5):462-8. doi: 10.1159/000321365. Epub 2010 Oct 18.
10
SOCS1 regulates the immune modulatory properties of mesenchymal stem cells by inhibiting nitric oxide production.细胞因子信号转导抑制因子1通过抑制一氧化氮的产生来调节间充质干细胞的免疫调节特性。
PLoS One. 2014 May 14;9(5):e97256. doi: 10.1371/journal.pone.0097256. eCollection 2014.

引用本文的文献

1
"Remodeling the intestinal immune microenvironment": immune regulation and tissue regeneration by mesenchymal stem/stromal cells in the repair microenvironment of inflammatory bowel disease.“重塑肠道免疫微环境”:间充质干/基质细胞在炎症性肠病修复微环境中的免疫调节与组织再生
Front Immunol. 2025 May 13;16:1543702. doi: 10.3389/fimmu.2025.1543702. eCollection 2025.
2
Innovative Therapeutic Strategies for Myocardial Infarction Across Various Stages: Non-Coding RNA and Stem Cells.心肌梗死各阶段的创新治疗策略:非编码RNA与干细胞
Int J Mol Sci. 2024 Dec 30;26(1):231. doi: 10.3390/ijms26010231.
3
Intracellular osteopontin potentiates the immunosuppressive activity of mesenchymal stromal cells.细胞内骨桥蛋白增强间充质基质细胞的免疫抑制活性。
Stem Cell Res Ther. 2024 Oct 15;15(1):366. doi: 10.1186/s13287-024-03979-8.
4
Stem Cell-Based or Cell-Free Gene Therapy in Chondrocyte Regeneration: Synovial Fluid-Derived Mesenchymal Stem Cell Exosomes.基于干细胞或无细胞的基因治疗在软骨细胞再生中的应用:滑液来源的间充质干细胞外泌体。
Curr Mol Med. 2024;24(7):906-919. doi: 10.2174/0115665240266016231014081916.
5
Nitric oxide-mediated the therapeutic properties of induced pluripotent stem cell for paraquat-induced acute lung injury.一氧化氮介导诱导多能干细胞治疗百草枯诱导的急性肺损伤的特性。
Front Immunol. 2023 May 18;14:1136290. doi: 10.3389/fimmu.2023.1136290. eCollection 2023.
6
Pretreated Mesenchymal Stem Cells and Their Secretome: Enhanced Immunotherapeutic Strategies.预处理间充质干细胞及其分泌组:增强的免疫治疗策略。
Int J Mol Sci. 2023 Jan 9;24(2):1277. doi: 10.3390/ijms24021277.
7
Mesenchymal Stem Cells and Psoriasis: Systematic Review.间充质干细胞与银屑病:系统综述。
Int J Mol Sci. 2022 Dec 1;23(23):15080. doi: 10.3390/ijms232315080.
8
Inhibition of the ATR agonistic autoantibody in a rat model of preeclampsia improves fetal growth in late gestation.在先兆子痫的大鼠模型中抑制 ATR 激动性自身抗体可改善妊娠晚期胎儿的生长。
Am J Physiol Regul Integr Comp Physiol. 2022 Nov 1;323(5):R670-R681. doi: 10.1152/ajpregu.00122.2022. Epub 2022 Sep 19.
9
Psoriatic Serum Induce an Abnormal Inflammatory Phenotype and a Decreased Immunosuppressive Function of Mesenchymal Stem Cells.银屑病血清诱导间充质干细胞出现异常炎症表型并降低其免疫抑制功能。
Int J Stem Cells. 2022 May 30;15(2):155-163. doi: 10.15283/ijsc20210.
10
MALAT-1/p53/miR-155/miR-146a ceRNA circuit tuned by methoxylated quercitin glycoside alters immunogenic and oncogenic profiles of breast cancer.由甲氧基化槲皮素糖苷调节的MALAT-1/p53/miR-155/miR-146a ceRNA回路改变了乳腺癌的免疫原性和致癌特征。
Mol Cell Biochem. 2022 Apr;477(4):1281-1293. doi: 10.1007/s11010-022-04378-4. Epub 2022 Feb 7.

本文引用的文献

1
How mesenchymal stem cells interact with tissue immune responses.间充质干细胞如何与组织免疫反应相互作用。
Trends Immunol. 2012 Mar;33(3):136-43. doi: 10.1016/j.it.2011.11.004. Epub 2012 Jan 7.
2
MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo.MicroRNA-138 调控人基质(间质)干细胞的成骨分化。
Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6139-44. doi: 10.1073/pnas.1016758108. Epub 2011 Mar 28.
3
Mesenchymal stem cells: mechanisms of inflammation.间充质干细胞:炎症机制。
Annu Rev Pathol. 2011;6:457-78. doi: 10.1146/annurev-pathol-011110-130230.
4
miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells.miR-155 及其星型伴侣 miR-155* 协同调控人浆细胞样树突状细胞 I 型干扰素的产生。
Blood. 2010 Dec 23;116(26):5885-94. doi: 10.1182/blood-2010-04-280156. Epub 2010 Sep 17.
5
Mesenchymal stem cells as therapeutics.间充质干细胞治疗。
Annu Rev Biomed Eng. 2010 Aug 15;12:87-117. doi: 10.1146/annurev-bioeng-070909-105309.
6
Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair.间充质干细胞:免疫抑制和组织修复的新策略。
Cell Res. 2010 May;20(5):510-8. doi: 10.1038/cr.2010.44. Epub 2010 Apr 6.
7
Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression.炎症细胞因子诱导间充质干细胞中细胞间黏附分子-1 和血管细胞黏附分子-1 的表达对于免疫抑制至关重要。
J Immunol. 2010 Mar 1;184(5):2321-8. doi: 10.4049/jimmunol.0902023. Epub 2010 Feb 3.
8
Physiological and pathological roles for microRNAs in the immune system.miRNAs 在免疫系统中的生理和病理作用。
Nat Rev Immunol. 2010 Feb;10(2):111-22. doi: 10.1038/nri2708.
9
MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation.MicroRNA-204 调节 Runx2 蛋白表达和间充质祖细胞分化。
Stem Cells. 2010 Feb;28(2):357-64. doi: 10.1002/stem.288.
10
MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue.miR-21 通过调节人脂肪组织来源间充质干细胞中的 TGF-β 信号转导来调控成脂分化。
Stem Cells. 2009 Dec;27(12):3093-102. doi: 10.1002/stem.235.